Granules India has received U.S. Food and Drug Administration approval for Lisdexamfetamine Dimesylate chewable tablets, its generic version of Takeda Pharmaceuticals’ central nervous system ...

Granules India Confident in USFDA Compliance, Focuses on New Products - Granules India , a Hyderabad-based pharmaceutical ...

On the first-day share sale process, the IPO was fully subscribed within minutes and closed with a 13.32 times subscription.

Granules India Limited is a large-scale vertically integrated company founded in March 18th, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI ...

Hyderabad-based US-focused pharma firm Granules India expects the new drug applications from its Gagillapur facility in ...